113 related articles for article (PubMed ID: 38280476)
1. Spermatid perinuclear RNA-binding protein promotes UBR5-mediated proteolysis of Dicer to accelerate triple-negative breast cancer progression.
Chen SY; Zhang FL; Zhang YL; Liao L; Deng L; Shao ZM; Liu GY; Li DQ
Cancer Lett; 2024 Apr; 586():216672. PubMed ID: 38280476
[TBL] [Abstract][Full Text] [Related]
2. CircUBR5 acts as a ceRNA for miR-1179 to up-regulate UBR5 and to promote malignancy of triple-negative breast cancer.
Gong G; She J; Fu D; Zhen D; Zhang B
Am J Cancer Res; 2022; 12(6):2539-2557. PubMed ID: 35812044
[TBL] [Abstract][Full Text] [Related]
3. E3 Ubiquitin Ligase UBR5 Drives the Growth and Metastasis of Triple-Negative Breast Cancer.
Liao L; Song M; Li X; Tang L; Zhang T; Zhang L; Pan Y; Chouchane L; Ma X
Cancer Res; 2017 Apr; 77(8):2090-2101. PubMed ID: 28330927
[TBL] [Abstract][Full Text] [Related]
4. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA Linc00339 promotes triple-negative breast cancer progression through miR-377-3p/HOXC6 signaling pathway.
Wang X; Chen T; Zhang Y; Zhang N; Li C; Li Y; Liu Y; Zhang H; Zhao W; Chen B; Wang L; Yang Q
J Cell Physiol; 2019 Aug; 234(8):13303-13317. PubMed ID: 30618083
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-1246 suppresses the metastasis of breast cancer cells by targeting the DYRK1A/PGRN axis to prevent the epithelial-mesenchymal transition.
Wang P; Chen W; Zhang Y; Zhong Q; Li Z; Wang Y
Mol Biol Rep; 2022 Apr; 49(4):2711-2721. PubMed ID: 35059968
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA LINC00885 upregulates NCK1 to promote cell viability and migration of triple-negative breast cancer cells through sponging miR-654-3p.
He P; Liu Z; Qi J; Shan J; Sheng J
Cancer Biomark; 2024; 39(1):63-78. PubMed ID: 37694355
[TBL] [Abstract][Full Text] [Related]
8. LncRNA DANCR upregulation induced by TUFT1 promotes malignant progression in triple negative breast cancer via miR-874-3p-SOX2 axis.
Wu G; Zhou H; Li D; Zhi Y; Liu Y; Li J; Wang F
Exp Cell Res; 2020 Nov; 396(2):112331. PubMed ID: 33058834
[TBL] [Abstract][Full Text] [Related]
9. DCAF13 promotes triple-negative breast cancer metastasis by mediating DTX3 mRNA degradation.
Liu J; Li H; Mao A; Lu J; Liu W; Qie J; Pan G
Cell Cycle; 2020 Dec; 19(24):3622-3631. PubMed ID: 33300431
[TBL] [Abstract][Full Text] [Related]
10. Regulation of cancerous progression and epithelial-mesenchymal transition by miR-34c-3p via modulation of MAP3K2 signaling in triple-negative breast cancer cells.
Wu J; Li WZ; Huang ML; Wei HL; Wang T; Fan J; Li NL; Ling R
Biochem Biophys Res Commun; 2017 Jan; 483(1):10-16. PubMed ID: 28069384
[TBL] [Abstract][Full Text] [Related]
11. LINC01096 knockdown inhibits progression of triple-negative breast cancer by increasing miR-3130-3p.
Wang GP; Mou ZL; Xu YY; Liu GX; Wang DM; Zhang HP
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7445-7456. PubMed ID: 31539132
[TBL] [Abstract][Full Text] [Related]
12. RBBP4 plays a vital role in the malignant progression of triple-negative breast cancer by regulating epithelial-mesenchymal transition.
Zheng Z; Yao X; Liu Y
Genes Genomics; 2022 Oct; 44(10):1301-1309. PubMed ID: 35622231
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-301a-3p promotes triple-negative breast cancer progression through downregulating MEOX2.
Liu H; Wang G
Exp Ther Med; 2021 Sep; 22(3):945. PubMed ID: 34306209
[TBL] [Abstract][Full Text] [Related]
14. CircNR3C2 promotes HRD1-mediated tumor-suppressive effect via sponging miR-513a-3p in triple-negative breast cancer.
Fan Y; Wang J; Jin W; Sun Y; Xu Y; Wang Y; Liang X; Su D
Mol Cancer; 2021 Feb; 20(1):25. PubMed ID: 33530981
[TBL] [Abstract][Full Text] [Related]
15. Up-regulated circBACH2 contributes to cell proliferation, invasion, and migration of triple-negative breast cancer.
Wang X; Xue B; Zhang Y; Guo G; Duan X; Dou D
Cell Death Dis; 2021 Apr; 12(5):412. PubMed ID: 33875646
[TBL] [Abstract][Full Text] [Related]
16. Circ_0000520 contributes to triple-negative breast cancer progression through mediating the miR-1296/ZFX axis.
Zhou Y; Ma G; Peng S; Tuo M; Li Y; Qin X; Yu Q; Kuang S; Cheng H; Li J
Thorac Cancer; 2021 Sep; 12(18):2427-2438. PubMed ID: 34324278
[TBL] [Abstract][Full Text] [Related]
17. MiR-92b inhibited cells EMT by targeting Gabra3 and predicted prognosis of triple negative breast cancer patients.
Li YY; Zheng XH; Deng AP; Wang Y; Liu J; Zhou Q; Cheng GY; Jiang Q
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10433-10442. PubMed ID: 31841197
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-543 inhibits the proliferation, migration, invasion, and epithelial-mesenchymal transition of triple-negative breast cancer cells via down-regulation of ACTL6A gene.
Wang YL; Liang RH; Wang CY; Zhang RP; Wu SY; Han X; Zhang GL
Clin Transl Oncol; 2022 Jan; 24(1):84-92. PubMed ID: 34181232
[TBL] [Abstract][Full Text] [Related]
19. Satellite double-stranded RNA induces mesenchymal transition in pancreatic cancer by regulating alternative splicing.
Iwata T; Kishikawa T; Seimiya T; Notoya G; Suzuki T; Shibata C; Miyakawa Y; Odawara N; Funato K; Tanaka E; Yamagami M; Sekiba K; Otsuka M; Koike K; Fujishiro M
J Biol Chem; 2024 Mar; 300(3):105742. PubMed ID: 38346537
[TBL] [Abstract][Full Text] [Related]
20. SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer.
Li M; Li A; Zhou S; Lv H; Yang W
J Hematol Oncol; 2019 Feb; 12(1):14. PubMed ID: 30736840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]